Elevated Triglyceride Content Diminishes the Capacity of High Density Lipoprotein to Deliver Cholesteryl Esters via the Scavenger Receptor Class B Type I (SR-BI)
Open accessAbstract
The selective uptake of high density lipoprotein (HDL) cholesteryl ester (CE) by the scavenger receptor class B type I (SR-BI) is well documented. However, the effect of altered HDL composition, such as occurs in hyperlipidemia, on this important process is not known. This study investigated the impact of variable CE and triglyceride (TG) content on selective uptake. CE selective uptake by Y1 and HepG2 cells was strongly affected by modification of either the CE or TG content of HDL. Importantly, TG, like CE, was selectively taken up by a dose-dependent, saturable process in these cells. As shown by ACTH up-regulation and receptor overexpression experiments, SR-BI mediated the selective uptake of both CE and TG. With in vitro modified HDLs of varying CE and TG composition, the selective uptake of CE and TG was dependent on the abundance of each lipid within the HDL particle. Furthermore, total selective uptake (CE + TG) remained constant, indicating that these lipids competed for cellular uptake. These data support a novel mechanism whereby SR-BI binds HDL and mediates the incorporation of a nonspecific portion of the HDL lipid core. In this way, TG directly affects the ability of HDL to donate CE to cells. Processes that raise the TG/CE ratio of HDL will impair the delivery of CE to cells via this receptor and may compromise the efficiency of sterol balancing pathways such as reverse cholesterol transport.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Elevated TG and insulin resistance may both impair HDL function and predate the development of diabetes.
“In this regard, elevated TG and insulin resistance may both impair HDL function37-39 and predate the development of diabetes.40”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [38]
Experimental studies suggest that hypertriglyceridemic HDL may be dysfunctional.
“Experimental studies suggest that hypertriglyceridemic HDL may be dysfunctional, 55,56 that small, dense LDL particles may be more susceptible to oxidative modification, 57,58 and that an increased number of atherogenic particles may adversely influence CVD risk 59 ; however, no clinical outcome trials to date have determined whether normalization of particle composition or reduction of particle”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [55]
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works
Phosphorus Assay in Column Chromatography
Bartlett, G. R. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70226-3 · Cited by 12,802 · see citing works
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,756 · see citing works
A simplification of the protein assay method of Lowry et al. which is more generally applicable
Peterson, G. L. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90043-4 · Cited by 8,531 · see citing works
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703 · see citing works
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059 · see citing works
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S. L., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,347 · see citing works
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,822 · see citing works
Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts
Goldstein, J. L., & Brown, M. S. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42341-7 · Cited by 1,485 · see citing works
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212 · see citing works
Plasma cholesteryl ester transfer protein
Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953 · see citing works
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 859 · see citing works
The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids
Rigotti, A., Acton, S. L., & Krieger, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16221 · Cited by 560 · see citing works
[24] Nondenaturing polyacrylamide gradient gel electrophoresis
Nichols, A. V., Krauss, R. M., & Musliner, T. A. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28084-2 · Cited by 522 · see citing works
Krieger, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.523 · Cited by 517 · see citing works
Glass, C. K., Pittman, R. C., Weinstein, D. B., & Steinberg, D. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5435 · Cited by 491 · see citing works
Single bilayer vesicles prepared without sonication physico-chemical properties
Brunner, J., Skrabal, P., & Häusser, H. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90308-4 · Cited by 384 · see citing works
Glass, C. K., Pittman, R. C., Civen, M., & Steinberg, D. H. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71160-9 · Cited by 380 · see citing works
Fluorometric determination of vitamin A in human blood and liver
Thompson, J. N., Erdödy, P., Brien, R., & Murray, T. K. (1971) · Biochemical Medicine · doi:10.1016/0006-2944(71)90076-7 · Cited by 324 · see citing works
Pittman, R. C., Knecht, T. P., ROSENBAUM, M. S., & Taylor, C. A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61524-8 · Cited by 322 · see citing works
Pittman, R. C., Carew, T. E., Glass, C. K., Green, S. R., Taylor, C. A., & Attie, A. (1983) · Biochemical Journal · doi:10.1042/bj2120791 · Cited by 318 · see citing works
Varban, M. L., Rinninger, F., Wang, N., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Gosselin, M. L., Dixon, K. L., Deeds, J. D., Acton, S. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4619 · Cited by 303 · see citing works
Johansson, J., Carlson, L. A., Landou, C., & Hamsten, A. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.174 · Cited by 259 · see citing works
Morton, R. E., & Zilversmit, D. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44293-1 · Cited by 246 · see citing works
Self-citationRigotti, A., Edelman, E. R., Seifert, P. A., Iqbal, S. N., Demattos, R. B., Temel, R. E., Krieger, M., & Williams, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33545 · Cited by 241 · see citing works
Temel, R. E., Trigatti, B. L., Demattos, R. B., Azhar, S., Krieger, M., & Williams, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13600 · Cited by 233 · see citing works
Webb, N. R., Connell, P. M., Graf, G. A., Smart, E. J., de Villiers, W. J. S., de Beer, F. C., & van der Westhuyzen, D. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15241 · Cited by 222 · see citing works
Xu, S., Laccotripe, M., Huang, X., Rigotti, A., Zannis, V. I., & Krieger, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37413-7 · Cited by 221 · see citing works
Gu, X.-J., Trigatti, B. L., Xu, S., Acton, S. L., Babitt, J. L., & Krieger, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26338 · Cited by 220 · see citing works
Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins
Jonas, A. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90062-m · Cited by 216 · see citing works
Scavenger receptor Bl - a cell surface receptor for high density lipoprotein
Rigotti, A., Trigatti, B. L., Babitt, J. L., Penman, M., Xu, S., & Krieger, M. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00009 · Cited by 209 · see citing works
Murakami, T., Michelagnoli, S., Longhi, R., Gianfranceschi, G., Pazzucconi, F., Calabresi, L., Sirtori, C. R., & Franceschini, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1819 · Cited by 201 · see citing works
High density lipoprotein conversion mediated by human plasma phospholipid transfer protein.
Tu, A. Y., Nishida, H. I., & Nishida, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49431-3 · Cited by 199 · see citing works
Rodrigueza, W. V., Thuahnai, S. T., Temel, R. E., Lund‐Katz, S., Phillips, M. C., & Williams, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20344 · Cited by 199 · see citing works
Plump, A. S., Erickson, S. K., Weng, W., Partin, J. S., Breslow, J. L., & Williams, D. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118716 · Cited by 178 · see citing works
Pittman, R. C., Glass, C. K., Atkinson, D., & SMALL, D. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61523-6 · Cited by 153 · see citing works
Collet, X., Tall, A. R., Serajuddin, H., Guendouzi, K., Royer, L. J., Oliveira, H. C. F., Barbaras, R., Jiang, X., & Francone, O. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33480-5 · Cited by 131 · see citing works
Williams, D. L., de la Llera-Moya, M., Thuahnai, S. T., Lund‐Katz, S., Connelly, M. A., Azhar, S., Anantharamaiah, G. M., & Phillips, M. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002411200 · Cited by 115 · see citing works
Lambert, G. C., Chase, M. B., Dugi, K. A., Bensadoun, A., Brewer, H. B., & Santamarina-Fojo, S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33491-x · Cited by 113 · see citing works
Biochemistry and biology of plasma lipoproteins
(1987) · International Journal of Biochemistry · doi:10.1016/0020-711x(87)90235-7 · Cited by 105 · see citing works
Rinninger, F., Kaiser, T., Mann, W. A., Meyer, N., Greten, H., & Beisiegel†, U. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32514-1 · Cited by 77 · see citing works
Grundy, S. M., Vega, G. L., Otvos, J. D., Rainwater, D. L., & Cohen, J. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33361-7 · Cited by 72 · see citing works
Biochemistry and biology of plasma lipoproteins
(1987) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(87)90084-x · Cited by 72 · see citing works
Cholesteryl ester transfer protein and its plasma regulator
Morton, R. E. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199908000-00006 · Cited by 70 · see citing works
Self-citationInteraction of lipid transfer protein with plasma lipoproteins and cell membranes
Morton, R. E. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01939693 · Cited by 60 · see citing works
Self-citationMorton, R., & Steinbrunner, J. V. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42340-5 · Cited by 55 · see citing works
Self-citationFluiter, K., & van Berkel, T. J. C. (1997) · Biochemical Journal · doi:10.1042/bj3260515 · Cited by 51 · see citing works
Serdyuk, A. P., & Morton, R. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.718 · Cited by 36 · see citing works
Self-citationRinninger, F., Kaiser, T., Windler, E. E. T., Greten, H., Fruchart, J., & Castro, G. R. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00082-4 · Cited by 33 · see citing works
Bruggen, D. V.-V., Kalkman, I., van Gent, T., van Tol, A., & Jansen, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32038 · Cited by 33 · see citing works
Green, S. R., & Pittman, R. C. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42069-3 · Cited by 29 · see citing works
Hilaire, N., Nègre‐Salvayre, A., & Salvayre, R. (1994) · Biochemical Journal · doi:10.1042/bj2970467 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · see citing works
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,087 · see citing works
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 752 · see citing works
“Consistent with these findings, HDL capacity to deliver CE to hepatic cells through interaction with SR-BI diminishes as a result of HDL enrichment in TG (Greene et al., 2001).”
ResultMiller, M., Cannon, C. P., Murphy, S. A., Qin, J., Ray, K. K., & Braunwald, E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.038 · Cited by 610 · see citing works
Rigotti, A., Miettinen, H. E., & Krieger, M. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0037 · Cited by 438 · see citing works
Unraveling the complexities of the HDL lipidome
Kontush, A., Lhomme, M., & Chapman, M. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036095 · Cited by 395 · see citing works
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
Zannis, V. I., Chroni, A., & Krieger, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0030-4 · Cited by 391 · see citing works
“SR-BI mediates both selective uptake of cholesteryl ester and other lipids [104, 124–126] from HDL [104, 127] and LDL [127, 128] to cells [104, 129, 130] and bidirectional unesterified cholesterol movement [131, 132].”
BackgroundHypertriglyceridaemia and risk of coronary artery disease
Reiner, Ž. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.31 · Cited by 386 · see citing works
Antiatherogenic small, dense HDL—guardian angel of the arterial wall?
Kontush, A., & Chapman, M. J. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0500 · Cited by 342 · see citing works
“The capacity of triglyceride-enriched HDL to deliver cholesteryl esters to hepatic cells through scavenger receptor BI is impaired”
BackgroundSchaap, F. G., Rensen, P. C. N., Voshol, P. J., Vrins, C. L. J., van der Vliet, H. N., Chamuleau, R. A. F. M., Havekes, L. M., Groen, A. K., & van Dijk, K. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403240200 · Cited by 300 · see citing works
KONES, R. J. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 257 · see citing works
“Moreover, the triglyceride-rich HDL uptake by SR-BI may be deficient, reducing the effectiveness of reverse cholesterol transport.(366) In diabetes, the typical lipid phenotype includes small, dense HDL particles, enriched with triglycerides and depleted of cholesteryl esters, which have lost 20%–50% of their antioxid…”
BackgroundEck, M. V., Twisk, J., Hoekstra, M., Rij, B. T. V., van der Lans, C. A. C., Bos, I. S. T., Kruijt, J. K., Kuipers, F., & van Berkel, T. J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211233200 · Cited by 238 · see citing works
High-Density Lipoprotein and Coronary Heart Disease
Natarajan, P., Ray, K. K., & Cannon, C. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.008 · Cited by 228 · see citing works
“Furthermore, triglyceride-rich DL-C cannot be taken by hepatocytes through scavenger eceptor B1 as readily, resulting in reduced efficacy of reverse holesterol transport (53,54).”
BackgroundTranslation of High-Density Lipoprotein Function Into Clinical Practice
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P. J., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2013) · Circulation · doi:10.1161/circulationaha.113.000962 · Cited by 224 · see citing works
“Specifically, HDL particles isolated from healthy individuals induce the expression of endothelial nitric oxide (NO) synthase (eNOS) and synthesis of NO by endothelial cells, inhibit adhesion molecule expression,35 promote endothelial cell migration contributing to endothelial repair,36 and attenuate tissue factor exp…”
BackgroundDysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
Otocka-Kmiecik, A., Mikhailidis, D. P., Nicholls, S. J., Davidson, M. H., Rysz, J., & Banach, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.03.003 · Cited by 205 · see citing works
“In addition, they cannot be readily taken up by the scavenger receptor B1 in the liver thus reducing the efficacy of RCT [57,58].”
BackgroundInfluentialMultiple actions of high-density lipoprotein
Florentin, M., Liberopoulos, E. N., Wierzbicki, A. S., & Mikhailidis, D. P. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283043806 · Cited by 200 · see citing works
Azhar, S., & Reaven, E. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00222-8 · Cited by 192 · see citing works
Annema, W., & von Eckardstein, A. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1025 · Cited by 182 · see citing works
The role of scavenger receptor class B type I (SR-BI) in lipid trafficking
Rhainds, D., & Brissette, L. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00173-0 · Cited by 169 · see citing works
HIV infection and high density lipoprotein metabolism
Rose, H. M., Hoy, J., Woolley, I. J., Tchoua, U., Bukrinsky, M., Dart, A. M., & Sviridov, D. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.018 · Cited by 153 · see citing works
“Although the ability of HDL particles from HIV-infected patients to promote cholesterol efflux remained intact, the increased triglyceride content of HDL may impact on binding and uptake of these particles by liver scavenger receptors, impairing cholesterol delivery through these receptors [23] and making HDL particle…”
BackgroundHigh-Density Lipoprotein Function and Dysfunction in Health and Disease
Chiesa, S. T., & Charakida, M. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-06846-w · Cited by 150 · see citing works
“However, they are likely explained by further downstream effects that may affect overall RCT, including a reduced ability for LCAT to convert free cholesterol to cholesterol esters [64], and a diminished capacity to deliver these cholesterol esters to hepatic cells via SR-BI [64, 67].”
BackgroundInfluentialHigh Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
Jomard, A., & Osto, E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00039 · Cited by 143 · see citing works
“Alterations in the lipidome, such as increase in triglycerides or decrease in phospholipids (67, 68), or a concomitant increase in surface rigidity due to an altered sphingomyelin to cholesterol ratio, reduce the RCT ability of HDLs, and its ability to associate to beneficial enzymes and proteins (69).”
BackgroundAccelerated Lipid Absorption in Mice Overexpressing Intestinal SR-BI
Biétrix, F., Yan, D., Nauze, M., Rolland, C., Bertrand‐Michel, J., Coméra, C., Schaak, S., Barbaras, R., Groen, A. K., Perret, B., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508868200 · Cited by 134 · see citing works
Scavenger Receptor Class B, Type I-mediated Uptake of Various Lipids into Cells
Thuahnai, S. T., Lund‐Katz, S., Williams, D. L., & Phillips, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106695200 · Cited by 129 · see citing works
HDL Biogenesis, Remodeling, and Catabolism
Zannis, V. I., Fotakis, P., Κούκος, Γ., Kardassis, D., Ehnholm, C., Jauhiainen, M., & Chroni, A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_2 · Cited by 113 · see citing works
“When it is bound to HDL, SR-BI mediates selective uptake of cholesteryl ester, triglycerides, phospholipids, and vitamin E from HDL to cells (Acton et al. 1996; Greene et al. 2001; Thuahnai et al. 2001; Stangl et al. 1999; Gu et al. 1998, 2000b; Urban et al. 2000).”
BackgroundDyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality
Graham, I. M., Cooney, M. T., Bradley, D., Dudina, A. L., & Reiner, Ž. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0313-7 · Cited by 109 · see citing works
“Furthermore, excess triglycerides in lipoproteins may result in abnormal transport [64, 65].”
Osgood, D. P., Corella, D., Demissie, S., Cupples, L. A., Wilson, P. W. F., Meigs, J. B., Schaefer, E. J., Coltell, Ó., & Ordovás, J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021664 · Cited by 110 · see citing works
“effects of the SR-BI overexpression (51).”
Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and “selective” pathway connection
Azhar, S. (2003) · Frontiers in bioscience · doi:10.2741/1165 · Cited by 109 · see citing works
“According to this model, HDL docks with SR-BI, forming a hydrophobic channel in which neutral core lipids, CE and TG are translocated to the plasma membrane (250).”
BackgroundMethodRole of Scavenger Receptors SR-BI and CD36 in Selective Sterol Uptake in the Small Intestine
Werder, M., Han, C., Wehrli, E., Bimmler, D., Schulthess, G., & Hauser, H. (2001) · Biochemistry · doi:10.1021/bi0109820 · Cited by 100 · see citing works
Liu, T., Krieger, M., Kan, H.-Y., & Zannis, V. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112103200 · Cited by 97 · see citing works
Bartlett, J., Predazzi, I. M., Williams, S. M., Bush, W. S., Kim, Y., Havas, S., Toth, P. P., Fazio, S., & Miller, M. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002436 · Cited by 96 · see citing works
“SBP 125 (34) 118 (20) 120 (38) 125 (53) 130 (38) 118 (18) 123 (30) 130 (19) 130 (36)”
Annema, W., & von Eckardstein, A. (2016) · Translational Research · doi:10.1016/j.trsl.2016.02.008 · Cited by 94 · see citing works
Scavenger Receptor BI Plays a Role in Facilitating Chylomicron Metabolism
Out, R., Kruijt, J. K., Rensen, P. C. N., Hildebrand, R. B., de Vos, P., Eck, M. V., & van Berkel, T. J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401170200 · Cited by 90 · see citing works
Khoudary, S. R. E., Chen, X., Nasr, A., Billheimer, J. T., Brooks, M. M., McConnell, D. S., Orchard, T. J., Crawford, S. L., Matthews, K. A., & Rader, D. J. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315355 · Cited by 78 · see citing works
LDL and HDL enriched in triglyceride promote abnormal cholesterol transport
Skeggs, J. W., & Morton, R. E. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100431-jlr200 · Cited by 73 · see citing works
“[ 3 H]cholesteryl ether and 125 I-tyramine-cellobiose-labeled HDL were prepared as previously described ( 24 ).”
BackgroundMethodInfluentialSelf-citationde Beer, M. C., Durbin, D. M., Cai, L., Mirocha, N., Jonas, A., Webb, N. R., de Beer, F. C., & van der Westhuyzen, D. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100228200 · Cited by 72 · see citing works
Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI
Nieland, T. J. F., Ehrlich, M., Krieger, M., & Kirchhausen, T. L. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.02.007 · Cited by 70 · see citing works
Catalano, G., Julia, Z., Frisdal, É., Vedie, B., Fournier, N., Goff, W. L., Chapman, M. J., & Guérin, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179416 · Cited by 68 · see citing works
DiMarco, D. M., Norris, G. H., Millar, C. L., Blesso, C. N., & Fernandez, M. L. (2017) · Journal of Nutrition · doi:10.3945/jn.116.241877 · Cited by 65 · see citing works
“A downside to this exchange is that HDLTG enrichment reduces its ability to take up cholesterol and interact with the hepatic transporters responsible for its uptake (16).”
BackgroundRhainds, D., Brodeur, M. R., Lapointe, J., Charpentier, D., Falstrault, L., & Brissette, L. (2003) · Biochemistry · doi:10.1021/bi026949a · Cited by 63 · see citing works
Ashraf, M. Z., Kar, N. S., Chen, X., Choi, J., Salomon, R. G., Febbraio, M., & Podrez, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710474200 · Cited by 60 · see citing works
Spotlight on HDL-raising therapies: insights from the torcetrapib trials
Kontush, A., Guérin, M., & Chapman, M. J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1191 · Cited by 59 · see citing works
“Consistent with this hypothesis, selective uptake of cholesteryl esters by hepatic cells is decreased with triglyceride-enriched HDL”
BackgroundReconstituted Discoidal ApoE-Phospholipid Particles Are Ligands for the Scavenger Receptor BI
Li, X., Kan, H.-Y., Lavrentiadou, S. N., Krieger, M., & Zannis, V. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200658200 · Cited by 57 · see citing works
Hormonal regulation of adrenal microvillar channel formation
Azhar, S., Nomoto, A. M., & REAVEN, E. P. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30459-4 · Cited by 56 · see citing works
New insight on the molecular mechanisms of high-density lipoprotein cellular interactions
Martinez, L. O., Jacquet, S., Terc�, F., Collet, X., Perret, B., & Barbaras, R. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4087-y · Cited by 54 · see citing works
Out, R., Hoekstra, M., de Jager, S. C. A., de Vos, P., van der Westhuyzen, D. R., Webb, N. R., Eck, M. V., Biessen, E. A. L., & van Berkel, T. J. C. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400361-jlr200 · Cited by 52 · see citing works
“In addition to CE, SR-BI selectively takes up a variety of other molecules, such as lipoprotein-associated PL (8, 9), HDL-associated CE hydroxides (10), and triglycerides (TGs) (9, 11).”
Wang, X.-N., Ye, P., Cao, R., Yang, X., Xiao, W., Zhang, Y., Bai, Y.-Y., & Wu, H.-M. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0266-8 · Cited by 59 · see citing works
“Indirectly, elevated TGs impairs the capacity of high density lipoprotein to deliver cholesteryl esters, which may promote atherosclerosis via the scavenger receptor class B Type I (SRBI) [23].”
BackgroundGoff, W. L., Settle, M., Greene, D. J., Morton, R. E., & Smith, J. D. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500255-jlr200 · Cited by 50 · see citing works
“LDL and HDL were isolated by sequential ultracentrifugation and radiolabeled in the presence of [(3)H]cholesteryl oleyl ether (COE), a nonhydrolyzable analog of CE, via cholesteryl ester transfer protein-mediated transfer from phospholipid/cholesterol liposomes, as described previously (11).”
MethodSelf-citationDenimal, D., Monier, S., Brindisi, M., Petit, J., Bouillet, B., Nguyen, A., Demizieux, L., Simoneau, I., de Barros, J.-P. P., Vergès, B. L., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309287 · Cited by 49 · see citing works
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
Salazar, J. J., Olivar, L. C., Ramos, E., Chávez-Castillo, M., Rojas, J., & Bermúdez, V. (2015) · Cholesterol · doi:10.1155/2015/296417 · Cited by 48 · see citing works
“ABCA-1: ATP-binding cassette transporter A-1 Apo A-I: Apolipoprotein A-I CAD: Coronary artery disease CE: Cholesteryl ester CETP: Cholesteryl ester transfer protein CVD: Cardiovascular disease CVR: Cardiovascular risk DM2: Type 2 diabetes mellitus FC: Free cholesterol HDL: High-Density Lipoprotein IDL: Intermediate-De…”
BackgroundInfluentialTriglyceride-to-HDL cholesterol ratio
Yunke, Z., Lü, G., & Zhenyue, C. (2013) · Herz · doi:10.1007/s00059-013-3788-0 · Cited by 45 · see citing works
Revealing the Role of High-Density Lipoprotein in Colorectal Cancer
Zeljković, A., Vekić, J., Mihajlović, M., Gojković, T., Vladimirov, S. S., Zeljković, D., Spasojević‐Kalimanovska, V., & Trifunović, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073352 · Cited by 43 · see citing works
“In addition, triglycerideenriched HDL particles have impaired function within the RCT process [36].”
BackgroundFunctionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy
Bellanger, N., Julia, Z., Villard, E. F., Khoury, P. E., Duchêne, E., Chapman, M. J., Fournier, N., Goff, W. L., & Guérin, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.027 · Cited by 39 · see citing works
Elevated CETP Activity Improves Plasma Cholesterol Efflux Capacity From Human Macrophages in Women
Villard, E. F., Khoury, P. E., Duchêne, E., Bonnefont‐Rousselot, D., Clément, K., Bruckert, É., Bittar, R., Goff, W. L., & Guérin, M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.252841 · Cited by 39 · see citing works
Rashid, S., Trinh, D. K. Y., Uffelman, K. D., Cohn, J. S., Rader, D. J., & Lewis, G. F. (2003) · Circulation · doi:10.1161/01.cir.0000070947.64595.47 · Cited by 40 · see citing works
Kim, C. H., Han, K. A., Yu, J., Lee, S. H., Jeon, H. K., Kim, S. H., Kim, S. Y., Han, K. H., Won, K., Kim, D.-B., et al. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.11.007 · Cited by 36 · see citing works
Cho, K., Nam, H.-S., Kang, D.-J., Park, M.-H., & Kim, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158623 · Cited by 34 · see citing works
“In addition, elevated TG content in HDL diminished the capacity of CE delivery via scavenger receptor class B type I (SR-BI) [28].”
BackgroundArtl, A., Marsche, G., Pussinen, P. J., Knipping, G., Sattler, W., & Malle, E. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00132-7 · Cited by 33 · see citing works
ABO Genotype, ‘Blood-Type’ Diet and Cardiometabolic Risk Factors
Wang, J., García‐Bailo, B., Nielsen, D. E., & El‐Sohemy, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084749 · Cited by 32 · see citing works
“High levels of TG are known to both impede the scavenging capacity of HDL [52,53] and promote the formation of small, dense LDL particles, which are more easily oxidized and thus”
BackgroundMechanisms of HDL deficiency in mice overexpressing human apoA-II
Julve, J., Escolá‐Gil, J. C., Ribas, V., González‐Sastre, F., Ordóñez‐Llanos, J., Sánchez‐Quesada, J. L., & Blanco‐Vaca, F. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200081-jlr200 · Cited by 32 · see citing works
“It is worthy to note that HDL composition affects selective cholesteryl ester uptake because triglyceride and cholesteryl esters compete for SR-BI-mediated cellular uptake ( 31 ).”
BackgroundSerum Triglyceride Levels and Cardiovascular Disease Events in Koreans
Kim, E. H., Lee, J. B., Kim, S., Jo, M., Hwang, J. Y., Bae, S. J., Jung, C. H., Lee, W. J., Park, J., Park, G., et al. (2015) · Cardiology · doi:10.1159/000380941 · Cited by 30 · see citing works
Denimal, D., Benanaya, S., Monier, S., Simoneau, I., de Barros, J.-P. P., Goff, W. L., Bouillet, B., Vergès, B. L., & Duvillard, L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac339 · Cited by 28 · see citing works
İşçen, S., & Zhenyue, C. (2013) · Herz · doi:10.1007/s00059-013-3840-0 · Cited by 28 · see citing works
Ito, F. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200320153410 · Cited by 27 · see citing works
Chang, H., Wang, Q., Shi, T., Huo, K., Li, C., Zhang, Q., Wang, G., Wang, Y., Tang, B., Wang, W., et al. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1083-3 · Cited by 27 · see citing works
“The cholesterol kit (COD-PAP Method), triglyceride kit (GPO-PAP Method), direct HDL kit and direct LDL kit were purchased from BiosinaTechnologies Inc. Evaluation of mRNA expressions of molecules involved in lipid metabolism by polymerase chain reaction (PCR) Expressions of LPL and CD36 in heart tissues were determine…”
BackgroundInfluentialGiorgi, N. D., Michelucci, E., Smit, J. M., Scholte, A. J. H. A., Mahdiui, M. E., Knuuti, J. M., Buechel, R. R., Teresińska, A., Pizzi, M. N., Roque, A., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.11.013 · Cited by 26 · see citing works
High Density Lipoprotein: Assembly, Structure, Cargo, and Functions
Murphy, A. J. (2013) · ISRN Physiology · doi:10.1155/2013/186365 · Cited by 26 · see citing works
“Therefore, SR-B1 has the ability to facilitate selective uptake CE and other lipids from both HDL and LDL into the cell, and either uptake or donate unesterified cholesterol [124, 136–142].”
BackgroundJulia, Z., Duchêne, E., Fournier, N., Bellanger, N., Chapman, M. J., Goff, W. L., & Guérin, M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p009746 · Cited by 26 · see citing works
Fernández‐Castillejo, S., Rubió, L., Hernáez, Á., Catalán, Ú., Pedret, A., Valls, R. M., Mosele, J. I., Covas, M., Remaley, A. T., Castañer, O., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700445 · Cited by 25 · see citing works
“[52] In summary, by using a model as VOO consumption in which improvements in HDL characteristics and functionality have been reported,[10,17–24] we looked for the major determinants of the CEC.”
BackgroundInfluentialArterial Stiffness Determinants for Primary Cardiovascular Prevention among Healthy Participants
Vallée, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092512 · Cited by 26 · see citing works
“Furthermore, elevated triglyceride levels can promote atherosclerosis through the scavenger receptor class B Type 1 (SR-BI) by impairing the capacity of high-density lipoprotein to deliver cholesteryl esters [58].”
BackgroundKostara, C. E., Ferrannini, E., Bairaktari, E. T., Papathanasiou, A. I., Elisaf, M., & Tsimihodimos, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228835 · Cited by 22 · see citing works
“the RCT, these particles negatively influence other important metabolic pathways involved in heart disease, including a reduced capacity for lecithin; less cholesterol acyltransferase (LCAT) to convert free cholesterol to cholesterol esters; and a diminished capacity to deliver cholesterol esters to hepatic cells via…”
BackgroundProtein Mediators of Sterol Transport Across Intestinal Brush Border Membrane
Brown, J. M., & Yu, L. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-8622-8_12 · Cited by 22 · see citing works
“Additionally, SR-BI can also promote selective uptake of free sterols, phospholipids, triglycerides, and cholesteryl ethers (Stangl et al., 1999, Urban et al., 2000, Greene et al., 2001).”
BackgroundMetabolic disorders and inflammation are associated with familial combined hyperlipemia
Díaz-Ruiz, M., Martínez-Triguero, M. L., López‐Ruiz, A., la Cruz, F. F.-D., Bañuls, C., & Hernández‐Mijares, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.09.009 · Cited by 18 · see citing works
Triglycerides: How Much Credit Do They Deserve?
Kohli, P., & Cannon, C. P. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.11.006 · Cited by 17 · see citing works
Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits
Rashid, S., Uffelman, K. D., Barrett, P. H. R., Vicini, P., Adeli, K., & Lewis, G. F. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31688-6 · Cited by 16 · see citing works
Scavenger Receptor Class B, Type I: A Promising Immunotherapy Target
Fioravanti, J., Medina‐Echeverz, J., & Berraondo, P. (2011) · Immunotherapy · doi:10.2217/imt.10.104 · Cited by 15 · see citing works
Mavridou, S., Venihaki, M., Rassouli, O., Tsatsanis, C., & Kardassis, D. (2010) · Endocrinology · doi:10.1210/en.2009-1302 · Cited by 15 · see citing works
Cardiovascular risk profile in burn survivors
Leung, B., Younger, J. F., Stockton, K. A., Müller, M. J., & Paratz, J. D. (2017) · Burns · doi:10.1016/j.burns.2017.07.010 · Cited by 14 · see citing works
Pedoman Tatalaksana Dislipidemia PERKI 2013
Erwinanto, E., Santoso, A., Putranto, J. N., Tedjasukmana, P., Suryawan, R., Rifqi, S., & Kasiman, S. (2015) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v34i4.385 · Cited by 14 · see citing works
Khoury, P. E., Plengpanich, W., Frisdal, É., Goff, W. L., Khovidhunkit, W., & Guérin, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.032 · Cited by 12 · see citing works
Enterocyte Fatty Acid Handling Proteins and Chylomicron Formation
Cifarelli, V., & Abumrad, N. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00048-7 · Cited by 13 · see citing works
Triglyceride and Cardiovascular Disease
Kim, M. (2013) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2013.2.1.1 · Cited by 11 · see citing works
Motte, A., Gall, J., Salem, J., Dasque, E., Lebot, M., Frisdal, É., Galier, S., Villard, E. F., Bouaziz-Amar, É., Lacorte, J., et al. (2020) · Biomolecules · doi:10.3390/biom10050810 · Cited by 11 · see citing works
“Those observations are entirely consistent with earlier studies showing that the CETP-mediated reduction in the CE/TG ratio in HDL particles due to a TG enrichment, as observed in subjects from GHigh as compared to GLow or during postprandial lipemia (Table 3) is associated with a significant decrease in the SR-BI-med…”
ResultKavanagh, K., Bashore, A. C., Davis, M. A., Jorgensen, M. J., McLouth, C. J., Beavers, D. P., & Parks, J. S. (2022) · Obesity · doi:10.1002/oby.23564 · Cited by 9 · see citing works
“Our study points to a clear shift toward larger HDL particle size, which can result from more TG content, and TG is known to interfere with CEC function [35].”
BackgroundMorton, R. E., & Izem, L. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m056333 · Cited by 10 · see citing works
Self-citationThe beneficial effects of HDL-C on atherosclerosis: rationale and clinical results
Santos‐Gallego, C. G., Torres, F., & Badimón, J. J. (2011) · Clinical Lipidology · doi:10.2217/clp.10.90 · Cited by 10 · see citing works
Nasr, A., Matthews, K. A., Janssen, İ., Brooks, M. M., Barinas‐Mitchell, E., Orchard, T. J., Billheimer, J. T., Wang, N. C., McConnell, D. S., Rader, D. J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac148 · Cited by 8 · see citing works
Metabolismus und Funktion der Lipoproteine hoher Dichte (HDL)
Jomard, A., & Osto, E. (2019) · Praxis · doi:10.1024/1661-8157/a003241 · Cited by 8 · see citing works
CD36 and Intestinal Fatty Acid Absorption
Nassir, F., & Abumrad, N. A. (2009) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152209788009823 · Cited by 8 · see citing works
Adrenocorticotrophic hormone retarded metabolism of low‐density lipoprotein in rats
Xu, N., Hurtig, M., Ekström, U., & Nilsson‐Ehle, P. (2004) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510410005730 · Cited by 8 · see citing works
Ducobu, J., Scheen, A. J., Gaal, L. V., Velkeniers, B., & Hermans, M. P. (2008) · Acta Cardiologica · doi:10.2143/ac.63.2.2029534 · Cited by 8 · see citing works
High-density lipoprotein: what is the best way to measure its antiatherogenic potential?
Remaley, A. T., & Warnick, G. R. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.7.773 · Cited by 8 · see citing works
Rayego‐Mateos, S., Morgado‐Pascual, J. L., García‐Caballero, C., Lázaro, I., Sala‐Vila, A., Opazo-Ríos, L., Mas, S., Egido, J., Ruiz‐Ortega, M., & Moreno, J. A. (2023) · The Journal of Pathology · doi:10.1002/path.6161 · Cited by 7 · see citing works
“The SR-BI is a scavenger receptor associated with the selective uptake or influx of HDL-derived cholesteryl esters and other lipids from HDLs and LDLs to cells [76,77].”
BackgroundHypertriglyceridemic waist: missing piece of the global cardiovascular risk assessment puzzle?
Arsenault, B. J., Després, J., & Boekholdt, S. M. (2011) · Clinical Lipidology · doi:10.2217/clp.11.51 · Cited by 6 · see citing works
Triglycerides and Cardiovascular Disease : A Scientific Statement From the
Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6 · see citing works
Enterocyte Fatty Acid Handling Proteins and Chylomicron Formation
Mansbach, C. M., & Abumrad, N. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00060-9 · Cited by 6 · see citing works
Briand, F., Bailhache, E., Nguyen, P., Krempf, M., Magot, T., & Ouguerram, K. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00588.x · Cited by 6 · see citing works
APOC3: Triglycerides do matter
Hassan, M. S. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.38 · Cited by 5 · see citing works
“(2) Triglyceride enrichment of high density lipoprotein (HDL) particles makes them dysfunctional.(5) (3) Postprandial triglycerides has been reported to induce apoptosis, and increase the expression of pro-inflammatory genes.”
BackgroundVallée, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288298 · Cited by 4 · see citing works
“damaging capacity of HDL to secrete cholesteryl esters [57].”
BackgroundRole of LCAT and Apo A-I in Newly Diagnosed HIV Patients
Mirajkar, A., Nikam, S., Nikam, P., & Patil, G. (2016) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-016-0631-4 · Cited by 3 · see citing works
“If this situation persists over long period of time, it may contribute to the increased risk of atherosclerosis [21].”
Background
- Authors
- Greene, D. J., Skeggs, J. W., & Morton, R. E.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Morton, Richard E.
- ORCID
- Morton, Richard E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 276
- Issue
- 7
- Pages
- 4804-4811
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2053088392
- Cited by
- 133
- References
- 52
- Citations by year
- 2025: 3 · 2023: 3 · 2022: 6 · 2021: 2 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 12 · 2012: 8
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL060934, HL60934)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- high-density lipoprotein, scavenger receptor class B type I, cholesteryl ester uptake, triglyceride content, HDL lipid composition, selective uptake, reverse cholesterol transport, sterol balance, hyperlipidemia, receptor overexpression
- MeSH terms
- Animals, Biological Transport, Cell Line, Cholesterol Esters, Humans, Lipoproteins, HDL, Membrane Proteins, Receptors, Immunologic, Substrate Specificity, Transfection, Triglycerides, Receptors, Lipoprotein, CD36 Antigens, COS Cells, Receptors, Scavenger, Scavenger Receptors, Class B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review